NYSE · Healthcare
PERRIGO Co plc (PRGO)
As-reported financials and recent SEC filings for PERRIGO Co plc, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$4.25B
Net income
$-1.43B
Net margin
-33.5%
Diluted EPS
$-10.29
ROE
-48.6%
P/E (TTM)
—
Market cap
$1.38B
Debt / equity
1.2×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.25B | $4.37B | $4.66B | $4.45B | $4.14B |
| Gross profit | $1.49B | $1.54B | $1.68B | $1.46B | $1.42B |
| Operating income | $-1.12B | $112.9M | $151.9M | $78.9M | $410.4M |
| Net income | $-1.43B | $-171.8M | $-12.7M | $-140.6M | $-68.9M |
| Diluted EPS | $-10.29 | $-1.25 | $-0.09 | $-1.04 | $-0.52 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
11-K2026-06-24
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →42026-06-16
View on EDGAR →SD2026-06-12
View on EDGAR →42026-06-09
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →Go deeper on PRGO
Search PERRIGO Co plc’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.